The Internet of Things (IoT) makes smart objects the ultimate building blocks in the development of cyber-physical smart pervasive frameworks. The IoT has a variety of application domains, including health care. The IoT revolution is redesigning modern health care with promising technological, economic, and social prospects. This paper surveys advances in IoT-based health care technologies and reviews the state-of-the-art network architectures/platforms, applications, and industrial trends in IoT-based health care solutions. In addition, this paper analyzes distinct IoT security and privacy features, including security requirements, threat models, and attack taxonomies from the health care perspective. Further, this paper proposes an intelligent collaborative security model to minimize security risk; discusses how different innovations such as big data, ambient intelligence, and wearables can be leveraged in a health care context; addresses various IoT and eHealth policies and regulations across the world to determine how they can facilitate economies and societies in terms of sustainable development; and provides some avenues for future research on IoT-based health care based on a set of open issues and challenges.

Non-orthogonal multiple access (NOMA) is one of the promising radio access techniques for performance enhancement in next-generation cellular communications. Compared to orthogonal frequency division multiple access, which is a well-known high-capacity orthogonal multiple access technique, NOMA offers a set of desirable benefits, including greater spectrum efficiency. There are different types of NOMA techniques, including power-domain and code-domain. This paper primarily focuses on power-domain NOMA that utilizes superposition coding at the transmitter and successive interference cancellation at the receiver. Various researchers have demonstrated that NOMA can be used effectively to meet both network-level and user-experienced data rate requirements of fifth-generation (5G) technologies. From that perspective, this paper comprehensively surveys the recent progress of NOMA in 5G systems, reviewing the state-of-the-art capacity analysis, power allocation strategies, user fairness, and user-pairing schemes in NOMA. In addition, this paper discusses how NOMA performs when it is integrated with various proven wireless communications techniques, such as cooperative communications, multiple-input multiple-output, beamforming, space–time coding, and network coding among others. Furthermore, this paper discusses several important issues on NOMA implementation and provides some avenues for future research.

Alzheimer’s disease (AD) is the most common type of dementia. Its diagnosis and progression detection have been intensively studied. Nevertheless, research studies often have little effect on clinical practice mainly due to the following reasons: (1) Most studies depend mainly on a single modality, especially neuroimaging; (2) diagnosis and progression detection are usually studied separately as two independent problems; and (3) current studies concentrate mainly on optimizing the performance of complex machine learning models, while disregarding their explainability. As a result, physicians struggle to interpret these models, and feel it is hard to trust them. In this paper, we carefully develop an accurate and interpretable AD diagnosis and progression detection model. This model provides physicians with accurate decisions along with a set of explanations for every decision. Specifically, the model integrates 11 modalities of 1048 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) real-world dataset: 294 cognitively normal, 254 stable mild cognitive impairment (MCI), 232 progressive MCI, and 268 AD. It is actually a two-layer model with random forest (RF) as classifier algorithm. In the first layer, the model carries out a multi-class classification for the early diagnosis of AD patients. In the second layer, the model applies binary classification to detect possible MCI-to-AD progression within three years from a baseline diagnosis. The performance of the model is optimized with key markers selected from a large set of biological and clinical measures. Regarding explainability, we provide, for each layer, global and instance-based explanations of the RF classifier by using the SHapley Additive exPlanations (SHAP) feature attribution framework. In addition, we implement 22 explainers based on decision trees and fuzzy rule-based systems to provide complementary justifications for every RF decision in each layer. Furthermore, these explanations are represented in natural language form to help physicians understand the predictions. The designed model achieves a cross-validation accuracy of 93.95% and an F1-score of 93.94% in the first layer, while it achieves a cross-validation accuracy of 87.08% and an F1-Score of 87.09% in the second layer. The resulting system is not only accurate, but also trustworthy, accountable, and medically applicable, thanks to the provided explanations which are broadly consistent with each other and with the AD medical literature. The proposed system can help to enhance the clinical understanding of AD diagnosis and progression processes by providing detailed insights into the effect of different modalities on the disease risk.

Brain is the controlling center of our body. With the advent of time, newer and newer brain diseases are being discovered. Thus, because of the variability of brain diseases, existing diagnosis or detection systems are becoming challenging and are still an open problem for research. Detection of brain diseases at an early stage can make a huge difference in attempting to cure them. In recent years, the use of artificial intelligence (AI) is surging through all spheres of science, and no doubt, it is revolutionizing the field of neurology. Application of AI in medical science has made brain disease prediction and detection more accurate and precise. In this study, we present a review on recent machine learning and deep learning approaches in detecting four brain diseases such as Alzheimer's disease (AD), brain tumor, epilepsy, and Parkinson's disease. 147 recent articles on four brain diseases are reviewed considering diverse machine learning and deep learning approaches, modalities, datasets etc. Twenty-two datasets are discussed which are used most frequently in the reviewed articles as a primary source of brain disease data. Moreover, a brief overview of different feature extraction techniques that are used in diagnosing brain diseases is provided. Finally, key findings from the reviewed articles are summarized and a number of major issues related to machine learning/deep learning-based brain disease diagnostic approaches are discussed. Through this study, we aim at finding the most accurate technique for detecting different brain diseases which can be employed for future betterment.

Chronic diseases are becoming more widespread. Treatment and monitoring of these diseases require going to hospitals frequently, which increases the burdens of hospitals and patients. Presently, advancements in wearable sensors and communication protocol contribute to enriching the healthcare system in a way that will reshape healthcare services shortly. Remote patient monitoring (RPM) is the foremost of these advancements. RPM systems are based on the collection of patient vital signs extracted using invasive and noninvasive techniques, then sending them in real-time to physicians. These data may help physicians in taking the right decision at the right time. The main objective of this paper is to outline research directions on remote patient monitoring, explain the role of AI in building RPM systems, make an overview of the state of the art of RPM, its advantages, its challenges, and its probable future directions. For studying the literature, five databases have been chosen (i.e., science direct, IEEE-Explore, Springer, PubMed, and science.gov). We followed the (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) PRISMA, which is a standard methodology for systematic reviews and meta-analyses. A total of 56 articles are reviewed based on the combination of a set of selected search terms including RPM, data mining, clinical decision support system, electronic health record, cloud computing, internet of things, and wireless body area network. The result of this study approved the effectiveness of RPM in improving healthcare delivery, increase diagnosis speed, and reduce costs. To this end, we also present the chronic disease monitoring system as a case study to provide enhanced solutions for RPMs.

Disease diagnosis is the identification of an health issue, disease, disorder, or other condition that a person may have. Disease diagnoses could be sometimes very easy tasks, while others may be a bit trickier. There are large data sets available; however, there is a limitation of tools that can accurately determine the patterns and make predictions. The traditional methods which are used to diagnose a disease are manual and error-prone. Usage of Artificial Intelligence (AI) predictive techniques enables auto diagnosis and reduces detection errors compared to exclusive human expertise. In this paper, we have reviewed the current literature for the last 10 years, from January 2009 to December 2019. The study considered eight most frequently used databases, in which a total of 105 articles were found. A detailed analysis of those articles was conducted in order to classify most used AI techniques for medical diagnostic systems. We further discuss various diseases along with corresponding techniques of AI, including Fuzzy Logic, Machine Learning, and Deep Learning. This research paper aims to reveal some important insights into current and previous different AI techniques in the medical field used in today’s medical research, particularly in heart disease prediction, brain disease, prostate, liver disease, and kidney disease. Finally, the paper also provides some avenues for future research on AI-based diagnostics systems based on a set of open problems and challenges.